Botulinum Toxin for First Bite Syndrome: A Symptom-Guided “Follow-The-Pain” Injection Strategy - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing Botulinum Toxin for Managing First Bite Syndrome: An Injection Approach Based on Symptom Localization

  • By

  • Rosario Marchese-Ragona

  • Gianmarco Giunta

  • Daniela Adamo

  • Elisabetta Zanoletti

  • Daniele Manfredini

  • Domenico Antonio Restivo

  • July 1, 2026

Share

Clinical Report: Utilizing Botulinum Toxin for Managing First Bite Syndrome

Background

First Bite Syndrome (FBS) is a postoperative pain condition characterized by severe, localized pain during the first bite of food, which can significantly impair quality of life. The condition is often associated with surgical procedures involving the parotid gland and can lead to food avoidance and psychological distress. Current management options are limited.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

  • FBS is characterized by unilateral parotid pain triggered by the first bite of a meal.
  • BoNT-A injections have shown efficacy in reducing first-bite pain intensity in case reports and small series.
  • Proposed mechanisms of BoNT-A include inhibition of acetylcholine release and modulation of pain-related mediators.
  • There is significant heterogeneity in injection techniques and dosing strategies among practitioners.
  • Current guidelines suggest considering BoNT-A for FBS when conventional treatments fail.

Clinical Implications

Clinicians should be aware of the potential role of BoNT-A in managing FBS, particularly in patients who do not respond to conventional therapies. Standardizing injection techniques and dosing may enhance treatment outcomes.

Conclusion

BoNT-A presents a promising option for managing FBS, but further research is needed to establish optimal treatment protocols.

Related Resources & Content

  1. Ali et al., 2008 -- First report of BoNT-A for FBS
  2. Shaikh et al., 2025 -- Systematic review on FBS management
  3. Korean Society of Laryngology, 2026 -- Guidelines for BoNT in otolaryngology
  4. Frontiers in Ophthalmology — Ultrasound-guided preseptal hydrodissection with 5% dextrose in water for persistent botulinum toxin-associated ptosis: a technical protocol
  5. Frontiers in Neurology — Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms
  6. Ophthalmology Management — Blepharospasm: The Condition and Treatment Options
  7. Evaluation of Outlet Type Constipation in Adults Following Treatment with Type A Botulinum Toxin: A Cohort Analysis
  8. Management of first bite syndrome: systematic review of recent evidence
  9. Guidelines for the Use of Botulinum Toxin in Otolaryngology
  10. Position Statement: Botulinum Toxin Treatment - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)

Original Source(s)

Related Content